Veeda in the News

Veeda to conduct bulk of $8.4 mn clinical research projects in India.

Nearly 60% of its global TO comes from India.http://blogs.veedacr.com/Lists/Categories/Category.aspx?Name=Veeda%20in%20the%20News


Columbus headquartered Veeda Oncology, a full service Oncology clinical research organisation (CRO) with facilities in North America, Europe and India, plans to conduct the bulk of the recent $8.4 million of new clinical research programs it has been awarded in the last one month in India itself. The awarded work will be conducted in India, Europe and the US. A large part of the clinical trials and data management and biostatistics work would be conducted in India. Matt Bowman, president and CEO of Veeda Oncology, said "We are enjoying our continued repeat business from our existing clients as well as these five new clients".


The CRO has invested around Rs75 crore in its Indian operations so far, and employs around 400 people. "We plan to recruit more people in India,US and Europe", the company said in an e-mailed response. Veeda Oncology is part of Veeda Group, the largest Phase I CRO in India also engaged in early clinical development and Phase II clinical research since 2005 having 6 offices across India, UK, USA & Europe.